Get startedLog in
    Picture of CK Life Sciences Intl (Holdings) logo

    775 — CK Life Sciences Intl (Holdings) Income Statement

    0.000.00%
    hk flag iconLast trade - 00:00
    Consumer DefensivesSpeculativeMid CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for CK Life Sciences Intl (Holdings), fiscal year end - December 31st, HKD millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    HKAS
    HKAS
    HKAS
    HKAS
    HKAS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue4,9435,4025,2765,3235,523
    Cost of Revenue
    Gross Profit1,4071,6301,6261,6371,693
    Selling / General / Administrative Expenses
    Depreciation and Amortization
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses4,6965,0674,9084,9325,277
    Operating Profit246335368391246
    Total Net Non Operating Interest Income / Expense
    Net Income Before Taxes11923820568.6-91.5
    Provision for Income Taxes
    Net Income After Taxes12516313217.3-127
    Minority Interest
    Net Income Before Extraordinary Items
    Net Income12516313217.3-127
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income12516313217.3-127
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS0.0110.0170.012-0.005-0.027
    Dividends per Share